Florence Healthcare and Slope join forces to strengthen processes

The companies say uniting will address research site demand for end-to-end solutions to increase efficiencies across all trials.

Slope is a global clinical trial execution platform for sites used by more than 75% of NCI-designated cancer centers for inventory and sample management. Florence Healthcare is a site enablement platform used by over 18,000 connected research sites in more than 55 countries.

The companies say the partnership stems from direct feedback from clinical researchers, recognizing their need for cohesive clinical technology across all trials, as opposed to the point solutions typically used trial by trial.

“The Slope-Florence partnership is a powerful combination. Florence’s vision to design a platform around sites’ needs to streamline operations, enable remote monitoring, and integrate study workflows is uniquely complementary to Slope,” says Rust Felix, CEO at Slope.

“Our combined solutions bring the industry one step closer to standardizing an end-to-end technology ecosystem built with and for sites.”

The Slope clinical trial execution platform provides an end-to-end workflow to ensure that research sites always have the right lab kits available while automatically guiding, documenting, and tracking all sample collection, processing, storing, and shipping activities. 

The integration of Slope’s platform with Florence’s Electronic Investigator Site File (eISF), eBinders, allows sites to transfer critical documents, such as Site & Study Biospecimen Reports, Clinical Inventory Reports, and Study Lab Manuals, directly to Florence, improving workflow and efficiency.